[Remote] Medical Science Liaison - Italy at Axsome Therapeutics Inc

Italy

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Biopharmaceutical, HealthcareIndustries

Requirements

Extensive travel throughout Italy (75%-80%)
Expertise in company's products and relevant therapeutic areas
Ability to build long-term relationships with KOLs, clinicians, academic institutions, and professional organizations
Knowledge of market dynamics, business development, and client feedback
Awareness of medical/clinical, regulatory, compliance, and quality issues in PTC therapeutic areas
Current knowledge of therapeutic advances, competing therapies/products, and competitor information

Responsibilities

Attends national and regional medical meetings and symposia as a representative of PTC, engages in discussions, attends scientific sessions and poster presentations, gathers information, summarizes findings, and cultivates professional relationships
Delivers (and may develop/design) fair-balanced and objective clinical and scientific presentations to HCPs, payors, and patient organizations in response to unsolicited requests for information on company products
Identifies and trains speakers for advisory boards, symposia, and educational programs with regulatory approved materials, slide sets, abstracts, posters, etc
Identifies, organizes, and carries out regional medical initiatives (e.g., advisory boards, round tables)
Provides input to management regarding alternative therapies, business development opportunities/risks, and stakeholder feedback
Establishes, manages, and maintains successful relations with relevant health authorities, including KOLs, HCPs, academic institutions, payors, patient organizations, etc
Facilitates the accurate and timely submission of applications for unrestricted educational grants or research initiatives and requests for support of studies, per company policy
Maintains thorough awareness of medical/clinical, regulatory, compliance, and quality issues and processes as they apply to PTC therapeutic areas and adheres to company standards
Maintains competitor information relevant to company’s therapeutic areas, goals/objectives, project activities, and product team priorities
Analyzes and applies relevant intelligence findings, communicates and presents insightful data/impact in an efficient format to appropriate internal stakeholders
Responsible for the scientific education of colleagues from other functions (e.g., commercial, marketing)

Skills

Key technologies and capabilities for this role

Medical Science LiaisonKOL EngagementRare DiseasesMedical AffairsTherapeutic Area ExpertiseRegulatory ComplianceScientific CommunicationMarket Dynamics

Questions & Answers

Common questions about this position

Is this a remote position or does it require travel?

This is a dedicated field-based position with extensive travel throughout Italy (75%-80%).

What are the main responsibilities of the Medical Science Liaison role?

Responsibilities include engaging with KOLs and clinicians, delivering scientific presentations to HCPs, organizing regional medical initiatives like advisory boards, attending medical meetings, and providing input on market dynamics and stakeholder feedback.

What is the company culture like at PTC Therapeutics?

PTC cultivates an inclusive culture where everyone feels valued, respected, and empowered, welcoming candidates from all backgrounds to foster a strong sense of belonging.

What salary or compensation does this position offer?

This information is not specified in the job description.

What makes a strong candidate for the MSL role in Italy?

Strong candidates should have expertise as clinical and medical experts in relevant therapeutic areas, experience building relationships with KOLs and HCPs, and the ability to deliver scientific presentations and organize medical initiatives.

Axsome Therapeutics Inc

Develops therapies for CNS disorders

About Axsome Therapeutics Inc

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain, which helps regulate mood. This drug has shown positive results in clinical trials and has received special FDA status to speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

New York City, New YorkHeadquarters

2012Year Founded

$430.7MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Performance Bonus

Company Equity

Risks

Increased competition from companies like Compass Pathways in the CNS market.

Potential delays in AXS-07 launch amid growing market anticipation.

Departure of key personnel like Lori Englebert may impact strategic direction.

Differentiation

Axsome focuses on CNS disorders with limited current treatment options.

AXS-05, an NMDA receptor antagonist, targets major depressive disorder and treatment-resistant depression.

Axsome's balanced portfolio includes both clinical and research stage products.

Upsides

FDA's fast-tracking of CNS treatments could expedite Axsome's drug approvals.

Increased investment in CNS R&D drives innovation, benefiting Axsome's pipeline.

Growing personalized medicine trend offers Axsome opportunities for tailored therapies.

Land your dream remote job 3x faster with AI

Try Jobo Free